FDA
FDA
07/06/2020
The FDA has approved a treatment option for adults with multidrug resistant HIV infection, marking a “new class of antiretroviral medications” for this patient population.
07/06/2020
FDA
FDA
06/15/2020
The US Food and Drug Administration approved a drug for the treatment of HIV-1 infection in conjunction with other antiretroviral therapies among children aged at least 4 weeks who weigh at least 3 kg. ...
06/15/2020
Public Health
Bruce Y. Lee, MD
Public Health
Urology
Urology
11/15/2019
The new antibacterial drug was approved after it was proven safe and effective in a study of 448 patients with complicated UTIs.
11/15/2019
Screening
Screening
11/07/2019
After performance data showed 95% sensitivity and specificity, the FDA authorized the assay’s marketing in the United States for detection of HIV-1 drug-resistant mutations.
11/07/2019
Screening
Screening
11/07/2019
After performance data showed 95% sensitivity and specificity, the FDA authorized the assay’s marketing in the United States for detection of HIV-1 drug-resistant mutations.
11/07/2019
Lung Infections
Lung Infections
08/15/2019
After a clinical trial showed positive results in 89% of participants, a new drug regimen was approved by the FDA for highly drug-resistant forms of pulmonary tuberculosis.
08/15/2019
FDA
FDA
07/17/2019
A new 3-drug antibacterial drug injection containing an FDA-approved antibiotic and a new β-lactamase inhibitor has been approved.
07/17/2019
FDA
FDA
06/04/2019
After a multinational, double-blind trial showed positive results, the FDA approved a new indication for an already-approved antibacterial drug.
06/04/2019
Immunizations
Immunizations
05/03/2019
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
05/03/2019